Stay updated on Enfortumab Vedotin in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enfortumab Vedotin in Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T04:00:05.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-05T18:54:43.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The status changed from 'No Results Posted' to 'Results Submitted', indicating that results are being prepared/uploaded for the study record.
    Difference
    0.0%
    Check dated 2026-02-26T14:20:18.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-12T03:50:56.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Footer revision label updated to v3.4.1, replacing the previous v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-05T01:31:35.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    The page now shows a glossary, updates the QC label capitalization (Last Update Submitted that Met QC Criteria), standardizes the No FEAR Act notice, and adds Revision: v3.4.0, replacing the previous Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T22:16:56.000Z thumbnail image

Stay in the know with updates to Enfortumab Vedotin in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin in Solid Tumors Clinical Trial page.